Does SECUKINUMAB Cause Injection site urticaria? 125 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Injection site urticaria have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
125
Reports of Injection site urticaria with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site urticaria From SECUKINUMAB?
Of the 125 reports, 5 (4.0%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Injection site urticaria Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Injection site urticaria?
DUPILUMAB (3,104)
ETANERCEPT (2,780)
ADALIMUMAB (2,188)
GLATIRAMER (1,091)
TIRZEPATIDE (842)
IXEKIZUMAB (652)
EVOLOCUMAB (486)
GALCANEZUMAB-GNLM (478)
DULAGLUTIDE (450)
HUMIRA (346)
Which SECUKINUMAB Alternatives Have Lower Injection site urticaria Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG